SARS-CoV-2 infection in free roaming dogs from the Amazonian jungle

Zambrano-Mila, Marlon S.; Freire‐Paspuel, Byron; Orlando, Solon Alberto; García-Bereguiaín, Miguel Angel

doi:10.1016/j.onehlt.2022.100387

Cited by 19 publications

(14 citation statements)

References 32 publications

(45 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Cats with active infection can emit the virus [ 2 , 5 , 7 , 10 , 11 ]. In addition, another study detected the virus in stray dogs from the Amazon rainforest [ 36 ]. This accumulating evidence suggests that an infection can occur in susceptible species independently from human contact, possibly via animal-to-animal transmission in accordance with SARS-CoV-2 ecology and biology.…”

Section: Discussionmentioning

confidence: 99%

Human ELISA Detects anti-SARS-CoV-2 Antibodies in Cats: Seroprevalence and Risk Factors for Virus Spread in Domestic and Stray Cats in Bulgaria

Sirakov

Rusenova

Rusenov

et al. 2023

Veterinary Sciences

View full text Add to dashboard Cite

The aim of this study was to verify whether the human DR-ELISA for the detection of anti-SARS-CoV-2 antibodies can be applied in cats, and to assess the risk factors that determine the spread of the virus among the cat population in Bulgaria. The study included 92 serum samples collected from 68 domestic and 24 stray cats aged from 3 months to 20 years of age in the period of January–June 2021. The samples originated from three regions in Bulgaria and from three places of inhabitance. DR-ELISA based on peroxidase-labeled SARS-CoV-2 N protein was employed to detect IgA, IgG and IgM antibodies in the samples. Subsequently, the results were compared with a commercially available multi-species ELISA kit. There was high seroprevalence (83.33%) in stray cats and 41.18% in domestic cats, confirmed by the human and veterinary ELISA kit. The positive cases in the regional cities were 42.86%, in small towns 50% and in villages 78.26%. Cats under 7 years had a five times higher risk than those over 7 years (p = 0.001). The risk was seven times higher for stray cats than for domestic cats (p = 0.001). In addition, the results indicate that the risk was the highest for cats in villages (p = 0.006) compared to cats in other places of inhabitance. This study demonstrates that human DR-ELISA may be successfully applied to monitor the circulation of SARS-CoV-2 in cats and other susceptible species. Cats might serve as sentinel animals for tracking the virus in nature and in inhabited areas (strays) and to discover asymptomatic cases in humans/owners.

show abstract

Section: Discussionmentioning

confidence: 99%

Human ELISA Detects anti-SARS-CoV-2 Antibodies in Cats: Seroprevalence and Risk Factors for Virus Spread in Domestic and Stray Cats in Bulgaria

Sirakov

Rusenova

Rusenov

et al. 2023

Veterinary Sciences

View full text Add to dashboard Cite

show abstract

“…SARS-CoV-2 is recognized as a generalist coronavirus 4 , showing a great capacity for infecting multiple animal species 5 , including pets, e.g. dogs 3,6,7 , cats 6,8,9 , and Syrian hamsters 10 ; zoo animals 11 , e.g. gorillas (https://www.science.org/content/article/captive-gorillas-test-positive-coronavirus), lions 12–14 , tigers 12,14 , mountain lion 13 , and Asian small-clawed otter (https://www.aphis.usda.gov/aphis/newsroom/stakeholder-info/sa_by_date/sa-2021/sa-04/covid-georgia-otters); farmed animals, e.g.…”

Section: Background and Summarymentioning

confidence: 99%

SARS-ANI: A Global Open Access Dataset of Reported SARS-CoV-2 Events in Animals

Nerpel

Yang

Sorger

et al. 2022

Preprint

View full text Add to dashboard Cite

The zoonotic origin of SARS-CoV-2, the etiological agent of COVID-19, is not yet fully resolved. Although natural infections in animals are reported in a wide range of species, large knowledge and data gaps remain regarding SARS-CoV-2 animal hosts. We used two major health databases to extract unstructured data and generated a comprehensive global dataset of thoroughly documented SARS-CoV-2 events in animals. The dataset integrates relevant epidemiological and clinical data on each event and is readily usable for analytical purposes. We also share the code for technical and visual validation of the data and created a user-friendly dashboard for data exploration. Data on SARS-CoV-2 occurrence in animals is critical to adapt monitoring strategy, prevent the formation of animal reservoirs, and tailor future human and animal vaccination programs. The FAIRness and analytical flexibility of the data will support research efforts on SARS-CoV-2 at the human-animal-environment interface. We intend to update this dataset weekly for at least one year and, through collaborative processes, to develop the dataset further and expand its use.

show abstract

“…Cães domésticos (Canis familiaris) são os animais de companhia mais populares no mundo, em contato íntimo com seus proprietários, e por esse motivo muito mais estudados que outras espécies de animais quanto à possibilidade de infecção pelo novo coronarívus. SARS-CoV-2 foi detectado em cães domésticos (Canis familiaris) em diversos estudos, porém esses animais apresentam-se assintomáticos ou com sinais e sintomas leves durante a infecção (Sit et al, 2020;Hamer et al, 2022;Barroso-Arévalo et al, 2022;Jairak et al, 2022;Medkour et al, 2022;Rivero et al, 2022;Zambrano-Mila et al, 2022). Embora a afinidade do receptor ACE2 de cães para o SARS-CoV-2 seja considerada alta (Wu et al, 2020;Koley et al, 2021;Ma & Gong, 2021;Zhang et al, 2021), esse fator não é o único preditor de susceptibilidade ao vírus (Wu et al, 2020;Koley et al, 2021;Ma & Gong, 2021;Piplani et al, 2021).…”

Section: O Vison Europeu (Mustela Vison) E O Vison Americano (Neoviso...unclassified

“…CoV-2 de cães para humanos(Naderi et al, 2022;Oliveira et al, 2022) Zambrano-Mila et al (2022). analisaram amostras de esfregaços orais e nasais de três cães de comunidades indígenas amazônicas com alta prevalência de COVID-19 entre humanos.…”

unclassified

Zoonose e zoonose reversa do SARS-CoV-2 sob a perspectiva da Saúde Única

Norberg¹,

Norberg²,

Mangiavacchi³

et al. 2022

RSD

View full text Add to dashboard Cite

Zoonoses não se processam em um único sentido na dinâmica de infecção, de animais para humanos. Assim como outras doenças, já vem sendo demonstrada a capacidade de infecção de animais pelo SARS-CoV-2 a partir do contato com humanos. O objetivo desse trabalho é realizar uma revisão narrativa, através da análise da literatura científica atual, quanto à possibilidade de zoonose e zoonose reversa do SARS-CoV-2 sob a perspectiva de Saúde Única e possíveis implicações para o futuro da evolução do vírus. Pesquisas recentes apontam que o vírus mostrou potencial de zoonose reversa, infectando mamíferos em diversas partes do planeta. Mustelídeos, hamsters, felinos e primatas do velho mundo são os animais que apresentaram maior susceptibilidade ao SARS-CoV-2. A zoonose reversa do SARS-CoV-2 favoreceu o surgimento de variantes cujas mutações mostraram-se adaptadas às diversas características fisiológicas particulares das espécies animais afetadas, com capacidade de retorno ao ser humano. O SARS-CoV-2 provavelmente será persistente entre mamíferos após a onda pandêmica que afetou a humanidade. Processos de mitigação da zoonose e zoonose reversa do SARS-CoV-2 sob a perspectiva da Saúde Única requerem ações em três níveis: ambiente humano, relações entre humanos e animais domésticos ou cativos, e vigilância e controle do vírus circulante entre animais de vida livre.

show abstract

SARS-CoV-2 infection in free roaming dogs from the Amazonian jungle

Cited by 19 publications

References 32 publications

Human ELISA Detects anti-SARS-CoV-2 Antibodies in Cats: Seroprevalence and Risk Factors for Virus Spread in Domestic and Stray Cats in Bulgaria

Human ELISA Detects anti-SARS-CoV-2 Antibodies in Cats: Seroprevalence and Risk Factors for Virus Spread in Domestic and Stray Cats in Bulgaria

SARS-ANI: A Global Open Access Dataset of Reported SARS-CoV-2 Events in Animals

Zoonose e zoonose reversa do SARS-CoV-2 sob a perspectiva da Saúde Única

Contact Info

Product

Resources

About